Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Healthcare Medical Devices
Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The Company’s segments include Scientific Equipment and Security Services. Scientific Equipment segment conducts scientific equipment manufacturing and sales, primarily as a patent-protected technology Company that develops... see more

Recent & Breaking News (TSXV:NSCI)

Nanalysis Announces Third Quarter 2024 Results

PR Newswire 1 day ago

Nanalysis Announces Third Quarter 2024 Conference Call

PR Newswire November 7, 2024

Nanalysis to Present at the LD Micro Main Event XVII

PR Newswire October 22, 2024

Nanalysis Scientific Corp. to Present at the 2024 Cantech Letter Conference in Toronto, ON

Newsfile October 3, 2024

Nanalysis Announces Second Quarter 2024 Results

PR Newswire August 28, 2024

Nanalysis Announces Second Quarter 2024 Conference Call

PR Newswire August 14, 2024

Nanalysis Announces New Director and Results of AGM

PR Newswire June 28, 2024

Nanalysis Announces Grant of Stock Options

PR Newswire June 7, 2024

Nanalysis Announces First Quarter 2024 Results

PR Newswire May 29, 2024

Nanalysis Announces First Quarter 2024 Conference Call

PR Newswire May 21, 2024

How a small-cap tech stock is broadening MRI technology

Jocelyn Aspa May 6, 2024

Nanalysis Announces Fourth Quarter and Full Year 2023 Results

PR Newswire April 29, 2024

/C O R R E C T I O N -- Nanalysis Scientific Corp./

PR Newswire April 24, 2024

Nanalysis Announces Full Year 2023 Conference Call

PR Newswire April 11, 2024

Nanalysis Scientific Corp. Announces Director Resignation

PR Newswire April 10, 2024

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances

PR Newswire April 4, 2024

NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND CONCURRENT PRIVATE PLACEMENT

Canada NewsWire March 20, 2024

Canadian Investment Regulatory Organization Trade Resumption - NSCI

Canada NewsWire March 6, 2024

Canadian Investment Regulatory Organization Trading Halt - NSCI

Canada NewsWire March 6, 2024

NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT

Canada NewsWire March 6, 2024
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >